‘Drug Injury’ Category

When Consumer Safety Does Not Seem to Matter

opioid lawyer AAJ article highlights the ongoing problem with corporations choosing money over honesty and consumer safety.

The American Association for Justice’s (AAJ) newest report highlights corporate misconduct and how it impacts the average U.S. citizen’s everyday life. A consistent lack of transparency from these corporations demonstrates how “when corporations put profits before safety and...

Xarelto vs. Aspirin…The Outcome May Shock You

Xarelto® attorneys According to a study, prescription Xarelto® shows no superiority compared to over-the-counter aspirin.

Bayer and Johnson & Johnson’s Janssen Research & Development have acknowledged that their Xarelto® (rivaroxaban) has failed a Phase III trial assessing the anticoagulant in patients with a recent embolic stroke of undetermined source (ESUS). In comparison with aspirin, Xarelto®...

Xarelto Dangers Investigated in Canada

The Canadian government has recently initiated a probe into the dangers associated with the blood thinner Xarelto (rivaroxaban). In July 2011, the U.S. Food & Drug Administration (FDA) approved the anti-clotting agent for patients receiving knee and hip replacements, to prevent strokes. Later the same year, the FDA expanded its approval of the prescription drug to include patients with...

Xarelto Lawsuits Filed at Increasing Rate

Recent U.S. Judicial Panel on Multidistrict Litigation statistics reveal a steady rise in the number of Xarelto lawsuits filed in federal court. Between May 15 and June 15, the increased filings were particularly high. Xarelto bleeding complications have been a problem for thousands of Americans who switched to Xarelto from the former anticoagulant of choice, warfarin (Coumadin).

In...

Xarelto Leads to Eye Bleeding, New Report Suggests

A new report suggests that Johnson & Johnson’s profit-churning blood thinner Xarelto may be linked to eye hemorrhaging. Xarelto lawsuits have already been filed across the country by people who have experienced uncontrollable bleeding while taking the drug. Unlike warfarin, Xarelto has no antidote once bleeding incidents occur.

Older Patients at Risk for Eye Hemorrhaging When...

New Study Suggests Xarelto May Double Risk of Gastrointestinal Bleeding

The British Medical Journal has recently published results from a new study indicating that Xarelto, as compared to the generic version of warfarin, may double the risk for gastrointestinal bleeding.

British Medical Journal Study of Xarelto Reviews 46,000 Patients

Xarelto has been described by its manufacturer as a prescription anticoagulant, or blood thinner, that is better than...

Xarelto Science Day Set By Court

Hundreds of Xarelto lawsuits filed in federal court have been transferred for pretrial procedures to the U.S. District Court in the Eastern District of Louisiana. These Xarelto lawsuits are now part of a Multi-District Litigation (MDL) established to handle the cases more efficiently by having one judge decide issues common to all lawsuits. On May 21, 2015, Judge Eldon E. Fallon ordered both...

Federal Judge Makes Important Ruling in Xarelto Lawsuits

As the number of Xarelto lawsuits rises due to the drug’s link to uncontrollable bleeding in patients, cases filed in federal court have been assigned to a single judge in the Eastern District of Louisiana — Judge Eldon Fallon. In May 2015, Judge Fallon ordered lawyers in the Xarelto lawsuits to select specific cases that will now enter the information-gathering stage of a lawsuit, known...

California Lawsuit Filed on Behalf Of 12 Injured by Xarelto

Bayer Corp. and Janssen Pharmaceuticals Inc. (a unit of Johnson & Johnson) have been sued in a California lawsuit by 12 people injured from using the companies’ blood thinner Xarelto. The plaintiffs who filed the California lawsuit were taking Xarelto to treat atrial fibrillation or to prevent the occurrence of dangerous blood clots. After taking the drug, they experienced either rectal...

Xarelto Lawsuit Filed in West Virginia Against Drug’s Makers

A West Virginia man is suing Janssen Research & Development and Bayer Corporation, along with several of their affiliates, for misrepresenting the risks associated with Xarelto. Jermaine Tavon McMillan’s lawsuit was filed in federal court in West Virginia in February.

Xarelto Defendants Chose Not to Test the Drug Adequately or Warn Sufficiently of Its Dangers

The Xarelto lawsuit...

What are my chances?

That’s the first question everyone asks. The truth is it’s impossible to know. But we can tell you this. Waters Kraus & Paul has what it takes to fight against big corporate interests and win. That’s why we’ve taken more mesothelioma trials to verdict than any other firm. And that’s why we’ve recovered more than $1.3 billion for clients like you. Do you think you have a case? Contact us now to speak with an attorney.

Call 800.226.9880